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AURORA ST. LUKE’S CARDIOLOGY AND HEART SURGERY PROGRAM
RANKED IN TOP 50 IN NATION BY U.S. NEWS & WORLD REPORT

T

he cardiology and heart surgery specialty at Aurora
St. Luke’s Medical Center was ranked 37th in the nation in
U.S. News & World Report’s 2017-18 Best Hospitals evaluation.
For the sixth year in a row, Aurora St. Luke’s is the only
Wisconsin heart program to achieve a national ranking.

Marie Golanowski, RN
President, Aurora St.
Luke's Medical Center

Jasbir Sra, MD
Co-Vice President,
Aurora Cardiovascular
and Thoracic
Service Line

Daniel P. O'Hair, MD
Co-Vice President,
Aurora Cardiovascular
and Thoracic
Service Line

“Patients with cardiac disease need care from highly
trained and experienced medical providers able to develop
targeted, individualized treatment strategies appropriate for
their health history and lifestyle needs,” said Jasbir Sra, MD,
co-vice president of the Aurora cardiovascular and
thoracic service line.
"This standout recognition of
“Our physicians
Aurora St. Luke's was achieved
and the staff who
support them are
thanks to the teamwork,
dedicated to this
passion and dedication of
mission, and it is
our caregivers. It demonstrates
an honor to be
that we are living our mission
recognized for
the success of
to help people live well."
these efforts.”
Marie Golanowski, MS, BS, BSN, RN
President, Aurora St. Luke's
Medical Center

The department’s scorecard included an
“excellent” ranking for 30-day survival of
patients, nurse staffing, use of advanced
technologies and patient services.
“Aurora’s state-of-the-art technology
enhances the physician’s ability to
deliver timely and accurate diagnoses,
life-saving cardiac treatments and
procedures, and reliable follow-up care,”
added Daniel P. O’Hair, MD, co-vice president of the
Aurora cardiovascular and thoracic service line.
“At Aurora St. Luke’s, the well-being of our patients is our
top priority,” Dr. O’Hair said. “We are committed to giving
every patient care from a highly skilled and compassionate
team of medical providers with cutting-edge technology at
their disposal.”
In addition, U.S. News & World Report labeled the Aurora
St. Luke’s program as “high performing,” the highest rank
possible, in each of the individual cardiac procedures it
studied: abdominal aortic aneurysm repair, aortic valve
surgery, heart bypass surgery and heart failure treatment.

continued on pg. 2
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AURORA ST. LUKE’S CARDIOLOGY AND HEART SURGERY PROGRAM
IN TOP 50 IN NATION continued from pg. 1
Aurora St. Luke’s cardiac and vascular program offers clinical acumen in structural heart
and peripheral vascular diseases, atrial fibrillation, channelopathies, heart failure and
pulmonary hypertension, inherited cardiomyopathies, adult congenital heart disease,
Marfan syndrome, and aortopathies. In addition, the program benefits from surgical
expertise, including in heart transplantation and ventricular assist device implantation,
and involvement in diverse clinical trials.
Aurora’s physician-researchers and the scientists from the Center for Integrative
Research on Cardiovascular Aging research team had 58 manuscripts published,
presented 71 abstracts, and wrote several textbook chapters in 2016. In addition, two
Aurora cardiologists have been first author on national clinical trial publications, and the
Aurora team is leading the world in a global transcatheter mitral valve replacement trial.
This year, 28 fellows-in-training are participating in Aurora Health Care’s active
Cardiovascular Disease, Interventional Cardiology, Clinical Cardiac Electrophysiology,
Advanced Clinical Electrophysiology and Heart Failure fellowship programs.

(Image courtesy of Medtronic)
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›D
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› C linical Trial: Aurora Takes
Part in AMPLATZER™ Amulet™
LAA Occluder Device Study
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CARDIOVASCULAR SURGERY

921

941

CABG on pump

792

816

With stent

908

1,032

CABG off pump

129

125

Without stent

866

1,328

Cardiac ablation – open (Maze)

122

212

Endarterectomy

Valve repair

93

77

486
326

495
327

69
24

39
38

479

854

Below knee

Surgical aortic valve replacement (SAVR)

356

718

Above knee

Surgical mitral valve replacement

104
19

114
22

272

334

Patent foramen ovale/atrial septal defect
closure total

98

111

Balloon valvuloplasty (percutaneous)

34

43

Transapical mitral valve replacement (TMVR)

14

4

Coronary artery bypass graft (CABG) total

Mitral valve repair
Other valve repair
VALVE REPLACEMENT
Valve replacement

Other surgical valve replacement
Transcatheter aortic valve replacement

HEART FAILURE AND TRANSPLANT
Ventricular assist device

50

39

Heart transplant

24

25

INTERVENTIONAL CARDIOLOGY
Heart catheterization total

8,194 9,051

Cardiac catheterization

6,057 6,531

Angiogram without pressures

2,137 2,520
2,376 2,361

Coronary intervention
With stent
Without stent
(Image courtesy of Abbott)

› Physician Recruitment

Myocardial biopsy

2,228 2,206
148
357

155
426

1,161
951

1,530
1,151

982
884

1,138
999

769
747

880
904

59

117

ELECTROPHYSIOLOGY
Cardioversion
EP study
Pacemaker
Ablation - percutaneous
Cardiac mapping
Defibrillator
Lead extraction

2 | CARDIOVASCULAR NEWS & VIEWS

2015 2016
VASCULAR MEDICINE
Peripheral vascular intervention

Carotid endarterectomy

1,774 2,360

Other endarterectomy

160

168

Lower extremity bypass

109

203

Amputation

192

230

136

157

56

70

194
166

168
147

AORTIC ANEURYSM DISEASE
Abdominal aortic aneurysm repair
Endovascular

28

21

Endovascular

125
29

292
37

Open

96

255

Open
Thoracic aortic aneurysm repair

CARDIAC IMAGING
Transthoracic echocardiography

69,977 68,952

Transesophageal echocardiography

2,948 2,708

Stress echocardiography

14,170 7,518

Myocardial perfusion, PET and other nuclear 17,328 16,863

644
477

494
528

Hypertrophic and inherited
cardiomyopathies patient visits

383

420

Adults and congenital heart disease
patient visits

218

422

Marfan Syndrome patient visits

94

94

Coronary computed tomography angiogram
Cardiac magnetic resonance imaging
SPECIALTY CENTERS

Check out Aurora's Cardiovascular
and Thoracic Outcomes at
aurora.org/heartandvascularoutcomes-report

AURORA TREATS FIRST PATIENT IN TRANSCATHETER
MITRAL VALVE REPLACEMENT TRIAL

AURORA MEDICAL
EDUCATION EVENTS

T

TBA | Milwaukee, WI
Greater Milwaukee
Heart Failure Society Series
Course Director: Nasir
Sulemanjee, MD

he first transcatheter mitral valve replacement
(TMVR) in the pivotal APOLLO Trial was successfully
performed at Aurora St. Luke’s Medical Center in
October. The trial aims to evaluate the Intrepid™
TMVR system (Medtronic, Dublin) for treatment of
patients with severe mitral valve regurgitation.

Find us on Facebook for 		
upcoming dates and speakers

Principal investigator,
cardiothoracic surgeon
Daniel P. O’Hair, MD, who also
Intrepid™ TMVR system
serves as co-vice president of the
(Image courtesy of Medtronic)
Aurora cardiovascular and thoracic
service line, and Tanvir K. Bajwa, MD, interventional cardiologist, led
the implantation team. They serve as Aurora’s lead investigators for
the global trial.
Daniel P. O’Hair, MD
Cardiothoracic Surgeon
Co-Vice President,
Aurora Cardiovascular
and Thoracic
Service Line

“TMVR represents a minimally invasive approach to treating mitral
regurgitation, which may mean shorter hospital stays, less pain
for patients and shorter recovery times when compared to openheart surgery,” Dr. Bajwa explained. “In addition, some people who
are not candidates for open-heart surgery may be able to benefit
from TMVR.”
Mitral regurgitation is the backward flow of blood through the mitral
valve into the atrium during left ventricular contraction. Untreated, it
can lead to heart failure or death.

Tanvir Bajwa, MD
Interventional
Cardiologist

5-6:30 P.M. | Every Tuesday
Milwaukee, WI
Tuesday Evening
Cardiology Conference
Milwaukee Research Institute –
accredited

Course Directors: Tanvir
Bajwa, MD; Rami Gal, MD
March 3, 2018 | Milwaukee, WI
New Developments
in Cardiology
Course Director: Tanvir
Bajwa, MD; Suhail Allaqaband, MD;
Jayant Khitha, MD

The APOLLO Trial is designed to evaluate the safety and efficacy
of the Intrepid TMVR system in up to 1,200 patients with severe,
symptomatic mitral valve regurgitation.

May 5, 2018 | Milwaukee, WI
Milwaukee Heart Failure
Symposium 2018
Course Directors: Nasir
Sulemanjee, MD; Vinay
Thohan, MD; Frank Downey, MD

A cohort of patients who are candidates for conventional openheart mitral valve replacement surgery but not eligible for mitral
repair will be randomized to receive either the Intrepid TMVR
system or surgical mitral valve replacement.

For information, contact
Laurel Landis at 414-219-7684
or laurel.landis@aurora.org.

A separate cohort will enroll patients for whom conventional open-heart surgery is
considered too great a risk. They will receive the Intrepid TMVR.
“Our team at Aurora Health Care has been a leader in transcatheter aortic valve
replacement since its advent, but until recently, effective options for TMVR were lacking,”
Dr. O’Hair said. “We are excited to continue to be on the forefront of a revolution in
cardiac care.”
The Intrepid TMVR system integrates self-expanding, dual-stent
technology with a replacement tissue heart valve that is delivered
to the heart by catheter. It is available for investigational use only,
and it is not approved for use outside of clinical studies.

PULMONARY
HYPERTENSION
PRECEPTORSHIP
CLINICS
April 18-19, June 6-7,
September 26-27,
October 24-25, 2018 |
Milwaukee, WI
Medical Director:
Dianne Zwicke, MD

For information about enrolling a patient in this trial, contact
Senior Research Coordinator Michelle Bennett, BSN, at
414-385-1889 or michelle.bennett@aurora.org.
Michelle Bennett, BSN
Senior Research
Coordinator

For information, contact
Patty Maglio, preceptorship
coordinator, at 414-646-1909
or patricia.maglio@aurora.org.
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CENTER FOR ADVANCED HEART FAILURE THERAPIES IMPLANTS 800TH VAD
Treating end-stage heart disease

T

he advanced heart failure team at Aurora St. Luke’s
Medical Center reached a new milestone in October
2017 when it implanted its 800th ventricular assist
device, giving a 58-year-old man with ischemic
cardiomyopathy the opportunity to live a full life
while he awaits heart transplantation.
The Donald and Rosemary Tendick, Sr., Center for
Advanced Heart Failure Therapies offers top-line care
to people with end-stage right and left heart disease,
supporting the patient through diagnosis and treatment
with a multidisciplinary team that includes:
• Heart failure cardiologists

• Thoracic surgeons

• Nurse practitioners		

• Pharmacists

• Biomedical engineers		

• Psychologists

• Nutritionists			

• Palliative care experts

Pulmonary Hypertension Clinic
“Pulmonary hypertension – high blood pressure in the
arteries in the lungs – stresses the heart and makes
breathing difficult. It can be challenging to accurately
diagnose,” Dr. Thohan explained.
Aurora’s Pulmonary Hypertension Clinic is one of only
47 in the nation accredited as a center of excellence by
the Pulmonary Hypertension Association. Experienced
experts help patients understand their diagnosis as well
as the treatment options and lifestyle changes that can
improve their health and quality of life.

• Pastoral care
“Our team has performed nearly 900 heart transplants
and now 800 artificial heart pumps, making our program
among the largest in the world to offer life-saving heart
replacement options,” said Vinay Thohan, MD, director of
the Center for Advanced Heart Failure Therapies.
Outcomes for transplanted grafts and patient mortality
rates exceed expected outcomes, based on the
Scientific Registry of Transplant Recipients website.
Ventricular-assist device implantation survival rates
exceed the InterMACs benchmarks for 180-day survival.

Vinay Thohan, MD, and his colleagues at Aurora Health Care’s Center for
Advanced Heart Failure Therapies (see below), use a multidisciplinary
approach to treat and support patients with end-stage heart disease.

Those same experts conduct research and take part
in clinical trials that allow them to offer the newest
treatments available. They also educate other physicians
throughout the nation about the best practices in
pulmonary hypertension treatment.
continued on next page 

AURORA HEALTH CARE'S CENTER FOR ADVANCED HEART FAILURE THERAPIES PHYSICIANS
Omar
Cheema, MD
Tendick Center
for Advanced
Heart Failure
Therapies

John
Crouch, MD
Aurora
Medical Group
Cardiovascular
and Thoracic
Surgery

Frank
Downey, MD
Aurora
Medical Group
Cardiovascular
and Thoracic
Surgery

T. Edward
Hastings, DO
Tendick Center
for Advanced
Heart Failure
Therapies

Asad
Ghafoor, MD
Tendick Center
for Advanced
Heart Failure
Therapies

Eric
Roberts, MD
Tendick Center
for Advanced
Heart Failure
Therapies

Nasir
Sulemanjee, MD
Tendick Center
for Advanced
Heart Failure
Therapies

Vinay
Thohan, MD
Tendick Center
for Advanced
Heart Failure
Therapies

Eric
Weiss, MD
Aurora
Medical Group
Cardiovascular
and Thoracic
Surgery

Dianne
Zwicke, MD
Tendick Center
for Advanced
Heart Failure
Therapies
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Heart Failure Research
The Center for Advanced Heart Failure Therapies is a soughtafter site for innovative bench-to-bedside research programs.
Physician-initiated and collaborative efforts have
consistently yielded data that can be used to meaningfully
improve patient care and quality of life.

In 2016, the center published 11 abstracts/posters at
national and international meetings and six manuscripts
for peer-reviewed journals.
Also, due to the quality and quantity of advanced heart
failure therapy options offered at the center, it is one of 50
sites nationally asked to participate in the development of
the next generation of artificial heart.

ADVANCED HEART FAILURE AND TRANSPLANT FELLOWSHIP PROGRAM TRAINS
NEXT GENERATION OF SPECIALISTS IN LATEST TECHNIQUES, PROCEDURES

T

he Advanced Heart Failure and Transplant Fellowship
Program at Aurora Health Care has been training
physicians for more than 10 years, providing a progressive
and structured curriculum with an emphasis on personalized
patient care, leadership skill development
and best research practices.
The program, designed to provide
a comprehensive clinical and
academic education, is instructed by a
multidisciplinary team of 10 dedicated
advanced heart failure and transplant
cardiologists and thoracic surgeons.
Nasir Sulemanjee, MD
Program Director,
Advanced Heart
Failure and Transplant
Fellowship

Nasir Sulemanjee, MD, serves as the
fellowship program director. He has been
in this role for the past six years.

The fellows spend their time at Aurora
St. Luke's Medical Center, a quaternary center in Milwaukee
that is one of 15 hospitals in the Aurora Health Care system.

Aurora St. Luke’s has an exceptionally high volume of all
advanced heart failure therapies, with its staff performing
25 to 35 heart transplants and implanting about 50 left
ventricular assist devices annually. It boasts the largest
experience in Wisconsin, with more than 850 heart transplants
and more than 800 mechanical circulatory support device
implantations since the inception of the program in 1984.
The Advanced Heart Failure and Transplant Fellowship Program
is accredited by the Accreditation Council for Graduate Medical
Education. It is a one-year track, with graduating fellows eligible
for American Board of Internal Medicine – Advanced Heart
Failure certification. The program has a 100% board pass rate,
and all of the past fellows have gone on to successful careers.
For information about Aurora’s Advanced Heart Failure
and Transplant Fellowship Program, contact Serena Messer
at 414-649-5841 or serena.messer@aurora.org, or visit
medicalprofessionals.aurorahealthcare.org/meded and
click on “Heart Failure.”

DR. RICHARD CARBALLO NAMED MEDICAL DIRECTOR FOR VASCULAR CARE

R

ichard Carballo, MD, has been named medical director
for vascular services at Aurora Health Care.

Dr. Carballo joined Aurora in 1995.
Prior to his new role, he served as
director of vascular surgery at Aurora
St. Luke’s Medical Center in Milwaukee.

In this position, Dr. Carballo provides strategic direction,
leadership and oversight in the development of a
multispecialty and multidisciplinary vascular program in
collaboration with the cardiovascular service line, medical
group leadership and local leadership.
Dr. Carballo and his team are responsible for ensuring that
integrated, high-quality, cost-effective and comprehensive
vascular services are available throughout Aurora’s network
of 15 hospitals and more than 150 clinics in Wisconsin and
northern Illinois. He oversees the consistent application
of clinical and administrative practices that reflect clinical
best practices and take into account quality, outcomes and
safety standards.

He received his medical degree from the
University of Illinois-Chicago, performed
his surgical graduate training at Loyola
University Chicago, and completed his
Richard Carballo, MD
vascular surgery fellowship at the Medical Medical Director,
Vascular Services
College of Wisconsin. His accreditations
include the National Board of Medical
Examiners and the American Board of Surgery.
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CLINICAL TRIAL: AURORA TAKES PART IN
AMPLATZER™ AMULET™ LAA OCCLUDER DEVICE STUDY

A

urora St. Luke’s Medical Center is the only Wisconsin-based
clinical trial site participating in a research study to test
the effectiveness of a new left atrial appendage (LAA) closure
device in reducing the risk of thromboembolism among
subjects with nonvalvular atrial fibrillation.
Electrophysiologist Jasbir Sra, MD, and
interventional cardiologist Tanvir Bajwa,
MD, are the local principal investigators
for the AMPLATZER Amulet LAA
Occluder Trial (Amulet IDE) (clinicaltrials.
gov identifier: NCT02879448).

Jasbir Sra, MD
Co-Vice President,
Aurora Cardiovascular
and Thoracic
Service Line

“Atrial fibrillation increases the risk of
stroke by five times,” explained Dr. Sra, covice president of the Aurora cardiovascular
and thoracic service line. “And when stroke
does occur, a person with atrial fibrillation
tends to have a worse prognosis.”
The AMPLATZER Amulet (manufactured
by Abbott) is designed to seal the left
atrial appendage, a small opening in the
left atrial muscle wall where blood can
clot and later re-enter the circulation,
possibly causing a stroke.

Tanvir Bajwa, MD
Interventional
Cardiologist

“LAA closure devices offer an alternative
to anticoagulant therapy in patients with
atrial fibrillation, avoiding the increased
bleeding risks associated with these
blood thinners,” Dr. Bajwa noted.

The Amulet IDE study is a
randomized, multicenter
active-control study being
The AMPLATZER Amulet left
conducted at various medical
atrial appendage occlusion device.
centers around the globe.
(Image courtesy of Abbott)
Subjects randomized to the
treatment arm will receive an Amulet LAA occlusion device,
while those in the control arm will receive a U.S. Food and
Drug Administration-approved LAA closure device.
To be eligible for the study, an adult patient must have
documented paroxysmal, persistent or permanent nonvalvular
atrial fibrillation and must not have been diagnosed with
rheumatic mitral valve heart disease. Further, the patient must
be at high risk of stroke or systemic embolism, and must
have an appropriate rationale for seeking an alternative to
anticoagulation medication.
The study will examine procedure-related complications,
device performance and participant
outcomes, including major bleeding,
ischemic stroke, systemic embolism
and death.
In the U.S., the Amulet is an
investigational device limited by
federal law to investigational use.
For more information, contact Senior
Research Coordinator Anthony
Chambers, BSN, at 414-385-2565
or anthony.chambers@aurora.org.

Anthony Chambers, BSN
Senior Research
Coordinator

PHYSICIAN RECRUITMENT
David Demos, MD • Thoracic Surgery
Dr. Demos joined the Cardiovascular and
Thoracic Surgery Department in July, and
practices at both Aurora St. Luke’s Medical
Center in Milwaukee and Aurora Medical Center
in Summit. He provides diagnosis and treatment for all
diseases of the lungs, airway, pleura, mediastinum, chest
wall and esophagus, utilizing minimally invasive and robotic
techniques. Dr. Demos earned his medical degree at the
Wayne State University School of Medicine in Detroit. He
completed his general surgery residency at Henry Ford
Hospital in Detroit, a Cardiothoracic Surgery Fellowship
at the Stanford University School of Medicine in Stanford,
California, and a Research Fellowship at the University of
Michigan Extracorporeal Life Support Laboratory. Dr. Demos
is board certified.
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Peter Diamond, MD • Noninvasive Cardiology
Dr. Diamond joined the Cardiology Department
at Aurora Memorial Hospital of Burlington in
June. He is board certified in internal medicine
and cardiovascular disease. After earning a
medical degree from the Loyola University Chicago Stritch
School of Medicine, he completed his residency and a
Cardiovascular Disease Fellowship at Loyola University Chicago.
Prior to joining Aurora Health Care, Dr. Diamond practiced in
Illinois, where he also served as a clinical assistant professor
of medicine in the Section of Cardiology at the University of
Illinois Hospital & Health Sciences System, at the University of
Illinois at Chicago. He is a fellow of the American College of
Cardiology, Society for Cardiac Angiography and Interventions,
and American College of Physicians, as well as a member of the
Alpha Sigma Nu Jesuit Honor Society and a clinical advisor of
the American Running and Fitness Association.

Patrycja Galazka, MD • Noninvasive Cardiology

Setu Trivedi, DO, MSE • Interventional Cardiology

Dr. Galazka completed an Advanced
Multimodality Cardiovascular Imaging Fellowship
at Brigham and Women’s Hospital in Boston
before taking a position with Aurora Health Care
in October. She sees patients at Aurora West Allis Medical
Center, and reads cardiovascular imaging studies at Aurora
St. Luke’s Medical Center in Milwaukee. Dr. Galazka’s clinical
interests include multimodality cardiovascular imaging,
preventive cardiology, women’s cardiovascular health and
valvular heart disease. She earned her medical degree at
Jagiellonian University Medical College in Krakow, Poland,
and completed her residency at Advocate Lutheran
General Hospital in Park Ridge, IL. She is fellowship trained
in Cardiovascular Disease and Multimodality Imaging. She
completed a program in clinical effectiveness at the Harvard
T.H. Chan School of Public Health, and is board certified in
internal medicine and cardiovascular disease.
Asad Ghafoor, MD • Advanced Heart
Failure Therapies
Dr. Ghafoor began seeing patients at the
Center for Advanced Heart Failure Therapies at
Aurora St. Luke’s Medical Center in Milwaukee
in September. He earned his medical degree from Khyber
Medical College in Peshawar, Pakistan, and undertook
his residency and a Cardiovascular Disease Fellowship at
the University of Arizona Medical Center in Tucson. He
completed an Advanced Heart Failure and Transplant
Cardiology Fellowship at the University of Michigan Health
System. Dr. Ghafoor is board certified in advanced heart
failure and transplant cardiology, cardiovascular disease and
internal medicine.
Rajeev Gupta, MD • Vascular Surgery
Dr. Gupta joined Aurora’s vascular surgery
program in July. He sees patients at Aurora
St. Luke’s Medical Center in Milwaukee and
Aurora West Allis Medical Center. Dr. Gupta
earned his medical degree at Sawai Man Singh Medical
College in Jaipur, India, and completed his residency in
general surgery and fellowship in vascular surgery at
Northwell Health in Manhasset, NY. He is board certified in
general and vascular surgery, and has earned the Registered
Physician in Vascular Interpretation® credential. Dr. Gupta
provides endovascular repair of abdominal and thoracic
aortic aneurysms, open and endovascular repair of aortoiliac
disease, carotid endarterectomy, endovascular intervention
for peripheral vascular disease, infrainguinal reconstruction,
inferior vena cava filter placement and retrieval, and
treatment for aortic dissection, renal or mesenteric vascular
diseases and varicose veins. Clinical interests include
combined open and endovascular revascularization for
peripheral vascular disease.

Dr. Trivedi, who joined the Cardiology
Department at Aurora Medical Center in
Kenosha in August, recently completed an
Interventional Cardiology Fellowship at Detroit
Medical Center. He also has completed a Cardiovascular
Disease Fellowship at Aurora Sinai/Aurora St. Luke’s Medical
Centers in Milwaukee. Dr. Trivedi earned his doctorate
in osteopathic medicine from Midwestern University’s
Arizona College of Osteopathic Medicine and completed
his residency at University Hospital in Cincinnati. He
holds a master’s degree in biomedical engineering with a
research focus in cardiovascular biomechanics. His clinical
interests include cardiac catheterization and percutaneous
coronary interventions.
Dajun Wang, MD • Interventional Cardiology
Dr. Wang joined the interventional cardiology
staff at Aurora Medical Center in Kenosha in
July, after graduating from the Cardiovascular
Disease and Interventional Cardiology
Fellowship programs at Aurora Sinai/Aurora St. Luke’s
Medical Centers in Milwaukee. He earned his medical degree
from the Medical College of Xi'An Jiaotong University in
Xi'an, China, and completed his residency at Aurora Sinai/
Aurora St. Luke’s. Dr. Wang is board certified in internal
medicine and cardiology. In addition to his clinical interests,
Dr. Wang has a strong background in medical research.
His practice interests include cardiac catheterization and
percutaneous coronary interventions. He is fluent in English
and Chinese (Mandarin).
Firas Zahwe, MD • Electrophysiology
Dr. Zahwe, board certified in clinical cardiac
electrophysiology, cardiovascular disease and
internal medicine, joined the staff at Aurora
St. Luke’s Medical Center in Milwaukee in July.
He provides complex arrhythmia mapping and ablation
for conditions including atrial fibrillation, atrial flutter,
supraventricular tachycardia, and ventricular arrhythmia;
non-pharmacological stroke management and prevention;
and advanced lead and device management, including
cardioverter-defibrillator (ICD), pacemaker, biventricular
device, subcutaneous ICD, and leadless pacemaker
implantation, as well as laser lead extraction. Dr. Zahwe
is interested in atrial fibrillation screening, management
and prevention and participates in local and national
clinical research studies. He has completed fellowships
in cardiovascular disease, cardiac electrophysiology and
advanced cardiac electrophysiology at Aurora Sinai/Aurora
St. Luke’s Medical Centers in Milwaukee. Dr. Zahwe earned
his medical degree from Tishreen University in Lattakia,
Syria and completed his residency at Advocate Christ
Medical Center in Chicago.
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 Aurora St. Luke’s Medical Center
Advanced medical services are available at Aurora’s
15 hospitals and 155 clinics located throughout
eastern Wisconsin and northern Illinois.

Mia Stone, MS, BSN, RN l Erin Heissel

Managing Editor | Jennifer Pfaff
Associate Editor | Susan Nord, MA
The information provided in Cardiovascular News and Views is geared toward
primary care physicians and cardiologists and is provided for educational purposes
only. Aurora has made every effort to ensure that the content of this newsletter
is accurate, correct and current, and Aurora is not liable for any unintentional
errors. References to websites and other resources have been chosen carefully, but
those references do not imply endorsement, and Aurora is not responsible or liable
for the information provided through those websites or other resources. Under no
circumstances will Aurora be liable under any theory of recovery for damages arising
out of or in any manner connected with the use of information from this newsletter.
The information presented in this newsletter is intended for general information and
educational purposes. It is not intended to replace the advice of your own physician.
Contact your physician if you believe you have a health problem.
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